Press Releases August 26, 2026 04:05 PM

iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference

iRhythm Holdings to Present at Wells Fargo 21st Annual Healthcare Conference

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
IRTC

iRhythm Holdings, a digital healthcare company specializing in wearable biosensor technology and data analytics for heart health, announced its participation in the Wells Fargo 21st Annual Healthcare Conference with a presentation scheduled for September 9, 2026.

iRhythm Holdings to Participate in Wells Fargo 21st Annual Healthcare Conference
IRTC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • iRhythm Holdings focuses on digital health care solutions that detect, predict, and prevent disease using wearable biosensors and data analytics.
  • The company will participate in the Wells Fargo 21st Annual Healthcare Conference presenting its latest developments to investors and analysts.
  • iRhythm's technology processes millions of heartbeats to provide clinically actionable cardiac health information, impacting the digital health sector.

SAN FRANCISCO, Aug. 26, 2026 (GLOBE NEWSWIRE) -- iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it will participate in the upcoming Wells Fargo 21st Annual Healthcare Conference.

iRhythm’s management is scheduled to present on Wednesday, September 9, 2026, at 8:45 a.m. ET. Interested parties may access a live and archived webcast of the fireside chat on the “Events & Presentations” section of the company’s investor website at investors.irhythmtech.com.

About iRhythm Holdings, Inc.
iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.

Investor Contact
[email protected]

Media Contact
Kassandra Perry
[email protected]


Risks

  • Market reaction may be muted as this event participation is informational without new product announcements or financial guidance.
  • Competition in the digital health and wearable biosensor market poses ongoing challenges for market share and growth.
  • Regulatory changes or reimbursement policies in healthcare may impact the adoption and revenue from iRhythm's solutions.

More from Press Releases

AWS and NVIDIA to Deliver 2 Million Additional GPUs and Next-Generation Infrastructure for Agentic and Physical AI Aug 26, 2026 Mercer International Inc. Announces C$20 Million (Approximately US$14 Million) in Government of Canada Support for its Peace River Mill Aug 26, 2026 NEW AMERICA ACQUISITION I CORP. ANNOUNCES CHIEF FINANCIAL OFFICER TRANSITION; Aug 26, 2026 Atlantic American Corporation Receives Nasdaq Notice Regarding Delayed Second Quarter Form 10-Q Filing Aug 26, 2026 Riverview Bancorp, Inc. Announces $4.0 Million Stock Repurchase Program Aug 26, 2026